Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
- PMID: 12771921
- PMCID: PMC2377107
- DOI: 10.1038/sj.bjc.6600920
Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
Abstract
Matrix metalloproteinases (MMPs), in particular the gelatinases (MMP-2 and -9), play a significant role in tumour invasion and angiogenesis. The expression and activities of MMPs have not been characterised in malignant mesothelioma (MM) tumour samples. In a prospective study, gelatinase activity was evaluated in homogenised supernatants of snap frozen MM (n=35), inflamed pleura (IP, n=12) and uninflammed pleura (UP, n=14) tissue specimens by semiquantitative gelatin zymography. Matrix metalloproteinases were correlated with clinicopathological factors and with survival using Kaplan-Meier and Cox proportional hazard models. In MM, pro- and active MMP-2 levels were significantly greater than for MMP-9 (P=0.006, P<0.001). Active MMP-2 was significantly greater in MM than in UP (P=0.04). MMP-2 activity was equivalent between IP and MM, but both pro- and active MMP-9 activities were greater in IP (P=0.02, P=0.009). While there were trends towards poor survival with increasing total and pro-MMP-2 activity (P=0.08) in univariate analysis, they were both independent poor prognostic factors in multivariate analysis in conjunction with weight loss (pro-MMP-2 P=0.03, total MMP-2 P=0.04). Total and pro-MMP-2 also contributed to the Cancer and Leukemia Group B prognostic groups. MMP-9 activities were not prognostic. Matrix metalloproteinases, and in particular MMP-2, the most abundant gelatinase, may play an important role in MM tumour growth and metastasis. Agents that reduce MMP synthesis and/or activity may have a role to play in the management of MM.
Figures



Similar articles
-
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.Gynecol Oncol. 2001 Aug;82(2):291-8. doi: 10.1006/gyno.2001.6243. Gynecol Oncol. 2001. PMID: 11531282
-
Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.Cancer. 2002 Mar 1;94(5):1466-75. doi: 10.1002/cncr.10355. Cancer. 2002. PMID: 11920503
-
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.Clin Cancer Res. 2004 Jan 15;10(2):634-40. doi: 10.1158/1078-0432.ccr-0864-02. Clin Cancer Res. 2004. PMID: 14760086
-
Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.Eur J Med Chem. 2021 Nov 5;223:113623. doi: 10.1016/j.ejmech.2021.113623. Epub 2021 Jun 12. Eur J Med Chem. 2021. PMID: 34157437 Review.
-
The role of gelatinases in colorectal cancer progression and metastasis.Biochim Biophys Acta. 2004 Dec 17;1705(2):69-89. doi: 10.1016/j.bbcan.2004.09.006. Biochim Biophys Acta. 2004. PMID: 15588763 Review.
Cited by
-
Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade.Cancers (Basel). 2020 Jul 11;12(7):1866. doi: 10.3390/cancers12071866. Cancers (Basel). 2020. PMID: 32664483 Free PMC article. Review.
-
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion.Sci Rep. 2020 Oct 7;10(1):16678. doi: 10.1038/s41598-020-72448-y. Sci Rep. 2020. PMID: 33028834 Free PMC article.
-
Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.J Carcinog. 2008 Jul 28;7:3. doi: 10.1186/1477-3163-7-3. J Carcinog. 2008. Retraction in: J Carcinog. 2008 Aug 08;7:4. doi: 10.1186/1477-3163-7-4. PMID: 18662397 Free PMC article. Retracted.
-
Overexpression of micro ribonucleic acid-591 inhibits cell proliferation and invasion of malignant pleural mesothelioma cells.Thorac Cancer. 2016 Apr 26;7(3):340-7. doi: 10.1111/1759-7714.12336. Epub 2016 Jan 31. Thorac Cancer. 2016. PMID: 27148420 Free PMC article.
-
Reactive oxygen species a double-edged sword for mesothelioma.Oncotarget. 2015 Jul 10;6(19):16848-65. doi: 10.18632/oncotarget.4253. Oncotarget. 2015. PMID: 26078352 Free PMC article. Review.
References
-
- Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K (2002) Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology 35: 1117–1124 - PubMed
-
- Antony VB, Hott JW, Godbey SW, Holm K (1996) Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8. Chest 109: 21S–22S - PubMed
-
- Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR (2000) Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 60: 4629–4637 - PubMed
-
- Baker EA, Bergin FG, Leaper DJ (2000) Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg 87: 1215–1221 - PubMed
-
- Baker EA, Leaper DJ (2002) Measuring gelatinase activity in colorectal cancer. Eur J Surg Oncol 28: 24–29 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous